カテゴリー： QYResearch, 世界

世界の組換えヒルジン薬市場 2019年

【英語タイトル】Global Recombinant Hirudin Medicine Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X14172）・商品コード：DATA909X14172
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、組換えヒルジン薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、12000 ATU / mg、16000 ATU / mg、16000 ATU / mg、その他に、用途別には、血栓症、腫瘍疾患、その他にセグメント区分し、組換えヒルジン薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・組換えヒルジン薬の世界市場概要
・組換えヒルジン薬の製造コスト構成分析
・組換えヒルジン薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・組換えヒルジン薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・組換えヒルジン薬のセグメント分析（種類別）
（12000 ATU / mg、16000 ATU / mg、16000 ATU / mg、その他）
・組換えヒルジン薬のセグメント分析（用途別）
（血栓症、腫瘍疾患、その他）
・組換えヒルジン薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Abbott、The Medicines Company、Teva Pharmaceutical、Pfizer、Pentapharm、）
・組換えヒルジン薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Recombinant Hirudin Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Recombinant Hirudin Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Hirudin Medicine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Hirudin Medicine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Recombinant Hirudin Medicine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott
The Medicines Company
Teva Pharmaceutical
Pfizer
Pentapharm
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
12000 ATU / mg
16000 ATU / mg
16000 ATU / mg
Others

Segment by Application
Thrombosis Disease
Tumor Disease
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Recombinant Hirudin Medicine
1.1 Definition of Recombinant Hirudin Medicine
1.2 Recombinant Hirudin Medicine Segment by Type
1.2.1 Global Recombinant Hirudin Medicine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 12000 ATU / mg
1.2.3 16000 ATU / mg
1.2.4 16000 ATU / mg
1.2.5 Others
1.3 Recombinant Hirudin Medicine Segment by Applications
1.3.1 Global Recombinant Hirudin Medicine Consumption Comparison by Applications (2014-2025)
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Global Recombinant Hirudin Medicine Overall Market
1.4.1 Global Recombinant Hirudin Medicine Revenue (2014-2025)
1.4.2 Global Recombinant Hirudin Medicine Production (2014-2025)
1.4.3 North America Recombinant Hirudin Medicine Status and Prospect (2014-2025)
1.4.4 Europe Recombinant Hirudin Medicine Status and Prospect (2014-2025)
1.4.5 China Recombinant Hirudin Medicine Status and Prospect (2014-2025)
1.4.6 Japan Recombinant Hirudin Medicine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Recombinant Hirudin Medicine Status and Prospect (2014-2025)
1.4.8 India Recombinant Hirudin Medicine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Hirudin Medicine
2.3 Manufacturing Process Analysis of Recombinant Hirudin Medicine
2.4 Industry Chain Structure of Recombinant Hirudin Medicine

3 Development and Manufacturing Plants Analysis of Recombinant Hirudin Medicine
3.1 Capacity and Commercial Production Date
3.2 Global Recombinant Hirudin Medicine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Recombinant Hirudin Medicine
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Recombinant Hirudin Medicine Production and Capacity Analysis
4.2 Recombinant Hirudin Medicine Revenue Analysis
4.3 Recombinant Hirudin Medicine Price Analysis
4.4 Market Concentration Degree

5 Recombinant Hirudin Medicine Regional Market Analysis
5.1 Recombinant Hirudin Medicine Production by Regions
5.1.1 Global Recombinant Hirudin Medicine Production by Regions
5.1.2 Global Recombinant Hirudin Medicine Revenue by Regions
5.2 Recombinant Hirudin Medicine Consumption by Regions
5.3 North America Recombinant Hirudin Medicine Market Analysis
5.3.1 North America Recombinant Hirudin Medicine Production
5.3.2 North America Recombinant Hirudin Medicine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Recombinant Hirudin Medicine Import and Export
5.4 Europe Recombinant Hirudin Medicine Market Analysis
5.4.1 Europe Recombinant Hirudin Medicine Production
5.4.2 Europe Recombinant Hirudin Medicine Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Recombinant Hirudin Medicine Import and Export
5.5 China Recombinant Hirudin Medicine Market Analysis
5.5.1 China Recombinant Hirudin Medicine Production
5.5.2 China Recombinant Hirudin Medicine Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Recombinant Hirudin Medicine Import and Export
5.6 Japan Recombinant Hirudin Medicine Market Analysis
5.6.1 Japan Recombinant Hirudin Medicine Production
5.6.2 Japan Recombinant Hirudin Medicine Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Recombinant Hirudin Medicine Import and Export
5.7 Southeast Asia Recombinant Hirudin Medicine Market Analysis
5.7.1 Southeast Asia Recombinant Hirudin Medicine Production
5.7.2 Southeast Asia Recombinant Hirudin Medicine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Recombinant Hirudin Medicine Import and Export
5.8 India Recombinant Hirudin Medicine Market Analysis
5.8.1 India Recombinant Hirudin Medicine Production
5.8.2 India Recombinant Hirudin Medicine Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Recombinant Hirudin Medicine Import and Export

6 Recombinant Hirudin Medicine Segment Market Analysis (by Type)
6.1 Global Recombinant Hirudin Medicine Production by Type
6.2 Global Recombinant Hirudin Medicine Revenue by Type
6.3 Recombinant Hirudin Medicine Price by Type

7 Recombinant Hirudin Medicine Segment Market Analysis (by Application)
7.1 Global Recombinant Hirudin Medicine Consumption by Application
7.2 Global Recombinant Hirudin Medicine Consumption Market Share by Application (2014-2019)

8 Recombinant Hirudin Medicine Major Manufacturers Analysis
8.1 Abbott
8.1.1 Abbott Recombinant Hirudin Medicine Production Sites and Area Served
8.1.2 Abbott Product Introduction, Application and Specification
8.1.3 Abbott Recombinant Hirudin Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 The Medicines Company
8.2.1 The Medicines Company Recombinant Hirudin Medicine Production Sites and Area Served
8.2.2 The Medicines Company Product Introduction, Application and Specification
8.2.3 The Medicines Company Recombinant Hirudin Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceutical
8.3.1 Teva Pharmaceutical Recombinant Hirudin Medicine Production Sites and Area Served
8.3.2 Teva Pharmaceutical Product Introduction, Application and Specification
8.3.3 Teva Pharmaceutical Recombinant Hirudin Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Pfizer
8.4.1 Pfizer Recombinant Hirudin Medicine Production Sites and Area Served
8.4.2 Pfizer Product Introduction, Application and Specification
8.4.3 Pfizer Recombinant Hirudin Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Pentapharm
8.5.1 Pentapharm Recombinant Hirudin Medicine Production Sites and Area Served
8.5.2 Pentapharm Product Introduction, Application and Specification
8.5.3 Pentapharm Recombinant Hirudin Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Recombinant Hirudin Medicine Market
9.1 Global Recombinant Hirudin Medicine Market Trend Analysis
9.1.1 Global Recombinant Hirudin Medicine Market Size (Volume and Value) Forecast 2019-2025
9.2 Recombinant Hirudin Medicine Regional Market Trend
9.2.1 North America Recombinant Hirudin Medicine Forecast 2019-2025
9.2.2 Europe Recombinant Hirudin Medicine Forecast 2019-2025
9.2.3 China Recombinant Hirudin Medicine Forecast 2019-2025
9.2.4 Japan Recombinant Hirudin Medicine Forecast 2019-2025
9.2.5 Southeast Asia Recombinant Hirudin Medicine Forecast 2019-2025
9.2.6 India Recombinant Hirudin Medicine Forecast 2019-2025
9.3 Recombinant Hirudin Medicine Market Trend (Product Type)
9.4 Recombinant Hirudin Medicine Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Recombinant Hirudin Medicine Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Recombinant Hirudin Medicine
Table Global Recombinant Hirudin Medicine Production (MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Hirudin Medicine Production Market Share by Types in 2018
Figure 12000 ATU / mg Product Picture
Figure 16000 ATU / mg Product Picture
Figure 16000 ATU / mg Product Picture
Figure Others Product Picture
Table Global Recombinant Hirudin Medicine Consumption (MT) Comparison by Applications (2014-2025)
Figure Global Recombinant Hirudin Medicine Consumption Market Share by Applications in 2018
Figure Thrombosis Disease
Figure Tumor Disease
Figure Others
Figure Global Recombinant Hirudin Medicine Revenue (Million USD) (2014-2025)
Figure Global Recombinant Hirudin Medicine Production (MT) (2014-2025)
Figure North America Recombinant Hirudin Medicine Market Size (Million USD) (2014-2025)
Figure Europe Recombinant Hirudin Medicine Market Size (Million USD) (2014-2025)
Figure China Recombinant Hirudin Medicine Market Size (Million USD) (2014-2025)
Figure Japan Recombinant Hirudin Medicine Market Size (Million USD) (2014-2025)
Figure Southeast Asia Recombinant Hirudin Medicine Market Size (Million USD) (2014-2025)
Figure India Recombinant Hirudin Medicine Market Size (Million USD) (2014-2025)
Table Recombinant Hirudin Medicine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Hirudin Medicine in 2018
Figure Manufacturing Process Analysis of Recombinant Hirudin Medicine
Figure Industry Chain Structure of Recombinant Hirudin Medicine
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Recombinant Hirudin Medicine Manufacturing Plants Distribution
Table Recombinant Hirudin Medicine Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Recombinant Hirudin Medicine Capacity (MT) of Major Manufacturers (2014-2019)
Table Recombinant Hirudin Medicine Production (MT) of Major Manufacturers (2014-2019)
Table Recombinant Hirudin Medicine Production Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Hirudin Medicine Production Share by Manufacturers in 2018
Table Recombinant Hirudin Medicine Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Recombinant Hirudin Medicine Revenue Market Share of Major Manufacturers (2014-2019)
Figure Recombinant Hirudin Medicine Revenue Share by Manufacturers in 2018
Table Recombinant Hirudin Medicine Average Price (USD/Kg) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Recombinant Hirudin Medicine Production by Regions 2014-2019 (MT)
Table Global Recombinant Hirudin Medicine Production Market Share by Regions 2014-2019
Figure Global Recombinant Hirudin Medicine Production Market Share by Regions in 2018
Table Global Recombinant Hirudin Medicine Revenue by Regions 2014-2019 (Million USD)
Table Global Recombinant Hirudin Medicine Revenue Market Share by Regions 2014-2019
Figure Global Recombinant Hirudin Medicine Revenue Market Share by Regions in 2018
Table Global Recombinant Hirudin Medicine Consumption by Regions 2014-2019 (MT)
Table Global Recombinant Hirudin Medicine Consumption Market Share by Regions 2014-2019
Figure North America Recombinant Hirudin Medicine Production Growth Rate 2014-2019 (MT)
Figure North America Recombinant Hirudin Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table North America Recombinant Hirudin Medicine Production, Consumption Import and Export (MT)
Figure Europe Recombinant Hirudin Medicine Production Growth Rate 2014-2019 (MT)
Figure Europe Recombinant Hirudin Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Recombinant Hirudin Medicine Production, Consumption Import and Export (MT)
Figure China Recombinant Hirudin Medicine Production Growth Rate 2014-2019 (MT)
Figure China Recombinant Hirudin Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table China Recombinant Hirudin Medicine Production, Consumption Import and Export (MT)
Figure Japan Recombinant Hirudin Medicine Production Growth Rate 2014-2019 (MT)
Figure Japan Recombinant Hirudin Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Recombinant Hirudin Medicine Production, Consumption Import and Export (MT)
Figure Southeast Asia Recombinant Hirudin Medicine Production Growth Rate 2014-2019 (MT)
Figure Southeast Asia Recombinant Hirudin Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Recombinant Hirudin Medicine Production, Consumption Import and Export (MT)
Figure India Recombinant Hirudin Medicine Production Growth Rate 2014-2019 (MT)
Figure India Recombinant Hirudin Medicine Revenue Growth Rate 2014-2019 (Million USD)
Table India Recombinant Hirudin Medicine Production, Consumption Import and Export (MT)
Figure Global Consumption Recombinant Hirudin Medicine Market Share by Application (2014-2019)
Figure Global Value (Consumption) Recombinant Hirudin Medicine Market Share by Application (2014-2019)
Table Abbott Recombinant Hirudin Medicine Production Sites and Area Served
Table Abbott Recombinant Hirudin Medicine Product Introduction, Application and Specification
Table Abbott Recombinant Hirudin Medicine Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Abbott Recombinant Hirudin Medicine Production Growth Rate (2014-2019)
Table Abbott Recombinant Hirudin Medicine Production Market Share (2014-2019)
Figure Abbott Recombinant Hirudin Medicine Revenue Market Share (2014-2019)
Table Abbott Recombinant Hirudin Medicine Main Business and Markets Served
Table The Medicines Company Recombinant Hirudin Medicine Production Sites and Area Served
Table The Medicines Company Recombinant Hirudin Medicine Product Introduction, Application and Specification
Table The Medicines Company Recombinant Hirudin Medicine Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table The Medicines Company Recombinant Hirudin Medicine Production Growth Rate (2014-2019)
Table The Medicines Company Recombinant Hirudin Medicine Production Market Share (2014-2019)
Figure The Medicines Company Recombinant Hirudin Medicine Revenue Market Share (2014-2019)
Table The Medicines Company Recombinant Hirudin Medicine Main Business and Markets Served
Table Teva Pharmaceutical Recombinant Hirudin Medicine Production Sites and Area Served
Table Teva Pharmaceutical Recombinant Hirudin Medicine Product Introduction, Application and Specification
Table Teva Pharmaceutical Recombinant Hirudin Medicine Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Recombinant Hirudin Medicine Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Recombinant Hirudin Medicine Production Market Share (2014-2019)
Figure Teva Pharmaceutical Recombinant Hirudin Medicine Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Recombinant Hirudin Medicine Main Business and Markets Served
Table Pfizer Recombinant Hirudin Medicine Production Sites and Area Served
Table Pfizer Recombinant Hirudin Medicine Product Introduction, Application and Specification
Table Pfizer Recombinant Hirudin Medicine Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Recombinant Hirudin Medicine Production Growth Rate (2014-2019)
Table Pfizer Recombinant Hirudin Medicine Production Market Share (2014-2019)
Figure Pfizer Recombinant Hirudin Medicine Revenue Market Share (2014-2019)
Table Pfizer Recombinant Hirudin Medicine Main Business and Markets Served
Table Pentapharm Recombinant Hirudin Medicine Production Sites and Area Served
Table Pentapharm Recombinant Hirudin Medicine Product Introduction, Application and Specification
Table Pentapharm Recombinant Hirudin Medicine Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Pentapharm Recombinant Hirudin Medicine Production Growth Rate (2014-2019)
Table Pentapharm Recombinant Hirudin Medicine Production Market Share (2014-2019)
Figure Pentapharm Recombinant Hirudin Medicine Revenue Market Share (2014-2019)
Table Pentapharm Recombinant Hirudin Medicine Main Business and Markets Served
Figure Global Recombinant Hirudin Medicine Production (MT) Growth Rate Forecast 2019-2025
Figure Global Recombinant Hirudin Medicine Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Recombinant Hirudin Medicine Sales Price (USD/Kg) Forecast 2019-2025
Figure North America Recombinant Hirudin Medicine Production Growth Rate Forecast 2019-2025 (MT)
Figure North America Recombinant Hirudin Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Recombinant Hirudin Medicine Production Growth Rate Forecast 2019-2025 (MT)
Figure Europe Recombinant Hirudin Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Recombinant Hirudin Medicine Production Growth Rate Forecast 2019-2025 (MT)
Figure China Recombinant Hirudin Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Recombinant Hirudin Medicine Production Growth Rate Forecast 2019-2025 (MT)
Figure Japan Recombinant Hirudin Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Recombinant Hirudin Medicine Production Growth Rate Forecast 2019-2025 (MT)
Figure Southeast Asia Recombinant Hirudin Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Recombinant Hirudin Medicine Production Growth Rate Forecast 2019-2025 (MT)
Figure India Recombinant Hirudin Medicine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (MT) of Recombinant Hirudin Medicine by Type (2019-2025)
Table Global Consumption (MT) of Recombinant Hirudin Medicine by Application (2019-2025)
Table Recombinant Hirudin Medicine Distributors List
Table Recombinant Hirudin Medicine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abbott、The Medicines Company、Teva Pharmaceutical、Pfizer、Pentapharm、

★調査レポート[世界の組換えヒルジン薬市場 2019年] (コード：DATA909X14172)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組換えヒルジン薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のヒルジン製品市場 2019年
    DATA909X09200 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヒルジン製品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、天然ヒルジン、組換えヒルジンに、用途別には、血栓症、腫瘍疾患、その他にセグメント区分し、ヒルジン製品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヒルジン製品の世界市場概要 ・ヒルジン製品の製造コスト構成分析 ・ヒルジン製品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヒルジン製品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヒルジン製品のセグメント分析（種類別） （天然ヒルジン、組換えヒルジン）...The global Hirudin Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hirudin Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hirudin Products market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hirudin Products in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hirudin Products manufacturing...
  • 世界の組み換えヒトエンドスタチン市場 2019年
    DATA909X14173 / QYResearch / 2019年11月20日 / ※本調査レポートは、組み換えヒトエンドスタチンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、純度：95％、その他に、用途別には、医療、科学研究、その他にセグメント区分し、組み換えヒトエンドスタチンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組み換えヒトエンドスタチンの世界市場概要 ・組み換えヒトエンドスタチンの製造コスト構成分析 ・組み換えヒトエンドスタチンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組み換えヒトエンドスタチンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組み換えヒトエンドスタチンのセグメント分析（種類別） （純度：95％、その他）...The global Recombinant Human Endostatin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Human Endostatin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Human Endostatin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Human Endostatin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の組換体抗体市場 2019年
    DATA909X14170 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換体抗体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、キメラ抗体、ヒト化抗体、完全ヒト抗体、単鎖抗体、二重特異性抗体に、用途別には、病院、科学研究、その他にセグメント区分し、組換体抗体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換体抗体の世界市場概要 ・組換体抗体の製造コスト構成分析 ・組換体抗体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換体抗体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換体抗体のセグメント分析（種類別） （キメラ抗体、ヒト化抗体、完全ヒト抗体、単鎖抗体、二重特異性抗体）...The global Recombinant Antibody market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Antibody volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Antibody market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Antibody in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Recombinant Antibody manufacturing...
  • 世界の組換え第VIII因子市場 2019年
    DATA909X14171 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換え第VIII因子の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、200IU、250IUに、用途別には、病院、薬局にセグメント区分し、組換え第VIII因子の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換え第VIII因子の世界市場概要 ・組換え第VIII因子の製造コスト構成分析 ・組換え第VIII因子の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換え第VIII因子の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換え第VIII因子のセグメント分析（種類別） （200IU、250IU）...The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Factor VIII market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Factor VIII in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の組換えペプチド市場 2019年
    DATA909X14174 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換えペプチドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルカゴン、カルシトニン、その他に、用途別には、インスリン、ヒト成長ホルモン、血液製剤、その他にセグメント区分し、組換えペプチドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換えペプチドの世界市場概要 ・組換えペプチドの製造コスト構成分析 ・組換えペプチドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換えペプチドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換えペプチドのセグメント分析（種類別） （グルカゴン、カルシトニン、その他）...The global Recombinant Peptides market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Peptides volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Peptides market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Peptides in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Recombinant Peptides manufacturing...
  • 世界の組換えタンパク質市場 2019年
    DATA909X14176 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換えタンパク質の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、分子クローニング、ポリメラーゼ連鎖反応に、用途別には、医薬品、生物工学、その他にセグメント区分し、組換えタンパク質の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換えタンパク質の世界市場概要 ・組換えタンパク質の製造コスト構成分析 ・組換えタンパク質の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換えタンパク質の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換えタンパク質のセグメント分析（種類別） （分子クローニング、ポリメラーゼ連鎖反応）...The global Recombinant Protein market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Protein volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Protein market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Protein in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Recombinant Protein manufacturing...
  • 世界の組換えタンパク質薬市場 2019年
    DATA909X14175 / QYResearch / 2019年11月20日 / ※本調査レポートは、組換えタンパク質薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、組換えDNA、組換えRNAに、用途別には、製薬産業、その他にセグメント区分し、組換えタンパク質薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・組換えタンパク質薬の世界市場概要 ・組換えタンパク質薬の製造コスト構成分析 ・組換えタンパク質薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・組換えタンパク質薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・組換えタンパク質薬のセグメント分析（種類別） （組換えDNA、組換えRNA）...The global Recombinant Protein Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Protein Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Protein Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Recombinant Protein Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆